Federal Register of Legislation - Australian Government

Primary content

PB 79 of 2010 Specifications as made
This Specification amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) and determines the list of pharmaceutical items that can be resupplied inside 20 days on the one prescription.
Administered by: Health
Registered 27 Jul 2010
Tabling HistoryDate
Tabled HR28-Sep-2010
Tabled Senate28-Sep-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 79 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Diana MacDonell, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated          19 July 2010

 

 

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment August 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 79 of 2010”.


 

2          Commencement

 

This Instrument commences on 1 August 2010.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, after item dealing with Carvedilol

insert in the columns in the order indicated:

 

Certolizumab pegol

Injection 200 mg in 1 mL single use pre-filled syringe

Injection

2

5

 

[2]                                  Schedule 1, after item dealing with Glyceryl Trinitrate

insert in the columns in the order indicated:

 

Golimumab

Injection 50 mg in 0.5 mL single use pre-filled pen

Injection

1

5

 

Injection 50 mg in 0.5 mL single use pre-filled syringe

Injection

1

5

 

[3]                                  Schedule 1, item dealing with Mesalazine

insert in the columns in the order indicated:

 

 

Tablet 1 g (prolonged release)

Oral

120

5

 

 

[4]                                  Schedule 1, after item dealing with Verapamil

insert in the columns in the order indicated:

 

Vildagliptin

Tablet 50 mg

Oral

60

5